Search results
23andMe CEO plans to take company private
MedTech Dive via Yahoo Finance· 5 days agoWojcicki's proposal as the new most likely outcome which should be welcomed by investors.” 23andMe has faced financial pressure as sales of DNA tests...
Pfizer's RSV vaccine shows potential to protect high-risk adults ages 18-59, widening possible use
CNBC· 2 weeks agoA vaccine from Pfizer showed the potential to protect adults ages 18 to 59 who are at increased risk...
SBJ Marketing: Is weight loss the next 'it' category?
Sports Business Journal· 2 weeks agoThe belief is that while regulations are beyond byzantine in pharmaceuticals, and changing with alarming frequency, the exploding diabetes/weight loss Rx category will be the next "it" category ...
Asthma Inhaler Chaos Leaves Us Doctors and the Children We Treat Out of Breath
US News & World Report· 5 days agoOn Jan. 10, Laura Goldstein went to her local Massachusetts pharmacy to fill her 4-year-old son’s prescription for Flovent, the go-to preventive asthma inhaler prescribed by pediatricians for ...
Aristotle Capital International Equity Q1 2024 Commentary
Seeking Alpha· 2 weeks agoAristotle Capital Management is an independent/employee-owned investment management organization...
Nelson Peltz Got Crushed by Disney. Can He Recover?
The Wall Street Journal· 6 days agoNelson Peltz’s proxy fight at Disney had the potential to help turn around his hedge fund after a tumultuous stretch. Instead, the activist investor’s...
Asthma Attack: Allergies, Rising Costs Impacting Patients
WebMD· 6 days agoAcross the U.S., warmer days have beckoned an earlier spring, and with that, an earlier pollen season and worse seasonal allergies. Pair that with an ongoing respiratory virus season – particularly ...
